This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6–12 July 2024 and includes updates on imported Oropouche human infections, Seasonal surveillance of West Nile virus infections, Locally acquired dengue, Yersinia enterocolitica, Cholera, Overview of respiratory virus epidemiology in the EU/EEA, Influenza A(H5N1), Mass gathering monitoring, Mpox and Middle Eastern Respiratory Syndrome (MERS).
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 June 2024 and includes updates on cholera, chikungunya and dengue, influenza, West Nile virus, and mass gathering monitoring or the UEFA European Football Championship and Hajj.
This report provides a record of the impact noted by countries on HIV services and monitoring capacity which can be used retrospectively to better understand the effects of the COVID-19 pandemic on the HIV situation in the European Region.
Mass gatherings can be anything from high-profile athletic events to religious gatherings or cultural events and festivals. ECDC aims to provide public health authorities in the EU/EEA countries with general considerations in relation to preparedness for organised mass gatherings, focusing on infectious disease threats.
This protocol describes the common methodology to be applied to established health data registries across seven participating EU/EEA Member States to estimate vaccine effectiveness for Coronavirus disease 2019 (COVID-19) in children and adolescents aged 5-17 years old.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season increase in norovirus, seasonal surveillance on West Nile virus infections, Middle East respiratory syndrome coronavirus (MERS-CoV), influenza A(H5N2), Oropouche virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
This report summarises results from an analysis conducted by ECDC and Eurofound to understand the impact of selected NPIs introduced from 2020 to 2022 in response to the COVID-19 pandemic on the WLB among EU adults.